The iShares Nasdaq Biotechnology ETF (IBB) is poised to open higher on Friday, boosted by Federal Reserve Chair Janet Yellen’s positive comments on the economy. Among …
Healthcare analysts weigh in on drug makers Relypsa Inc (NASDAQ:RLYP) and Intercept Pharmaceuticals Inc (NASDAQ:ICPT), as one explores potential sale and the other gets closer to FDA …
Intercept Pharmaceuticals Inc (NASDAQ:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, …
Leerink and Wedbush analysts highlight potential catalysts for Intercept Pharmaceuticals Inc (NASDAQ:ICPT) and bluebird bio Inc (NASDAQ:BLUE). One analyst believes that better than expected briefing …
Valeant Pharmaceuticals Intl Inc Shares of Valeant Pharmaceuticals are rising nearly 10% today, after the company announced that an Ad Hoc Committee has completed its review …
Twitter Inc (NYSE:TWTR) is up over 2% in pre-market trading after Bloomberg reported that it will broadcast NFL games online on Thursday nights. …
Healthcare analysts weigh in on pharmaceutical giant Gilead Sciences, Inc. (NASDAQ:GILD) and liver disease firm Intercept Pharmaceuticals Inc (NASDAQ:ICPT).
Moving a pipeline drug from inception to commercialization can take years for biotech companies. Analysts weigh in on upcoming catalysts for Sarepta Therapeutics …
As Intercept Pharmaceuticals Inc (NASDAQ:ICPT) approaches a crucial date for FDA approval of a liver disease treatment and Rexahn Pharmaceuticals, Inc (NYSE:RNN) announces its YE15 earnings …
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, …
